// App-Quantinova.ai

870 : Dosing, Patient Satisfaction and Other Patient-Reported Outcomes after Switching to Rurioctocog Alfa Pegol in Athn 2: A Longitudinal, Observational Study of Previously Treated Hemophilia Patients Switching Coagulation Replacement Factor Products

Researchers

Presenter

  • Janna M. Journeycake

Principal Investigators

  • Michael Recht

  • Christine Guelcher

  • Ellis J. Neufeld

  • Margaret V. Ragni

  • Robert F. Sidonio Jr

  • Cliff Takemoto

  • Michael D Tarantino

  • Dunlei Cheng

  • Susan U. Lattimore

  • Jorge Caicedo

  • Michael Denne

Medical Centers

  • Jimmy Everest Center for Cancer and Blood Disorders, University of Oklahoma Health Sciences Center, Oklahoma City

  • American Thrombosis and Hemostasis Network, Rochester, NY

  • Children's National Health System, Center for Cancer and Blood Disorders, Washington, DC

  • St. Jude Children's Research Hospital, Memphis, TN

  • Department of Medicine, Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA

  • Hemophilia of Georgia Center for Bleeding and Clotting Disorders, Aflac Cancer and Blood Disorders Center, Children’s Healthcare of Atlanta, Decatur, GA

  • St. Jude Children's Research Hospital, Memphis, TN

  • Bleeding & Clotting Disorders Institute, Peoria, IL

  • Hemophilia Treatment Center, Oregon Health and Science University, Portland, OR

  • Takeda Pharmaceuticals U.S.A., Inc.,Lexington,Stati Uniti

  • Takeda, Cambridge, MA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Hemophilia

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • rurioctocog alfa

  • FVIII

Outcome

  • N/A

Study Design

  • Observational

  • Multicenteric

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • American Thrombosis And Hemostasis Network (ATHN)

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved